Pioneering Proof of
Concept Trials with
Excellence
We Lead the Way in Early Stage Drug Development
Your Trusted Proof of Concept (POC) Partner
Drug development faces escalating complexity, time demands, and costs, requiring efficient strategies to bring new compounds to market successfully. Proof of Concept (POC) studies play a crucial role by evaluating initial efficacy and safety. The challenge is to demonstrate the superiority of new drugs efficiently within budget constraints, ensuring successful market introduction.
Our comprehensive trials include POC, First-in-Human (FiH), and specialized patient population studies, all meticulously designed to provide insights into drug efficacy and safety profiles.
Accelerate Drug Development Success with POC Studies
POC studies determine drug feasibility for full development by detecting significant effects compared to placebo or other treatments. They balance small sample sizes with statistical power to detect drug effects and explore dose-response relationships.
Optimize your Phase I/II clinical trials with our expertise in FiH and independent POC studies across diverse demographics: healthy volunteers, and patients with diabetes, obesity, Non-Alcoholic Steatohepatitis (NASH), and Non-Alcoholic Fatty Liver Disease (NAFLD). Depending on study needs, we recruit significant patient cohorts or collaborate with trusted Contract Research Organizations (CROs).
We offer three state-of-the-art facilities located in Kiel, Mannheim, and Berlin, with a total of 160 beds. This makes us the largest and longest-established early-stage CRO in Europe, with over 40 years of experience. Our dedicated team of experts in regulatory affairs, bioanalytics, project management, and medical writing ensures precise study execution and reliable outcomes for your drug development needs.
Partner with CRS to advance your drug development initiatives and enhance patient care. Contact us today to discuss how our tailored solutions can accelerate your path to success.